How internal R&D at DCN Dx is helping solve common diagnostic test failures.
This whitepaper shares how DCN Dx’s in-house R&D led to the creation of sample adequacy controls—tools that help ensure the right sample, in the right amount, gets applied during testing. Designed for blood, urine, and saliva assays, these markers improve reliability in home-use and point-of-care settings.
You’ll get a look at the real problems these innovations address, the science behind them, and how they can be adopted without derailing your existing development process.
What You’ll Learn
- What sample adequacy controls actually do
- Why they matter for home-use and OTC tests
- How they reduce false results
- What makes DCN Dx’s controls unique
- How they support faster, cleaner regulatory review
